1. Home
  2. TYRA vs WWW Comparison

TYRA vs WWW Comparison

Compare TYRA & WWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

N/A

Current Price

$22.30

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Wolverine World Wide Inc.

WWW

Wolverine World Wide Inc.

N/A

Current Price

$21.97

Market Cap

1.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
TYRA
WWW
Founded
2018
1883
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Shoe Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.6B
IPO Year
2021
2003

Fundamental Metrics

Financial Performance
Metric
TYRA
WWW
Price
$22.30
$21.97
Analyst Decision
Strong Buy
Buy
Analyst Count
15
11
Target Price
★ $47.45
$24.30
AVG Volume (30 Days)
563.7K
★ 923.9K
Earning Date
11-20-2026
11-12-2026
Dividend Yield
N/A
★ 1.88%
EPS Growth
N/A
★ 96.55
EPS
N/A
★ 0.61
Revenue
N/A
★ $1,874,300,000.00
Revenue This Year
N/A
$6.78
Revenue Next Year
N/A
$5.83
P/E Ratio
★ N/A
$35.07
Revenue Growth
N/A
★ 6.80
52 Week Low
$13.83
$14.00
52 Week High
$40.65
$23.84

Technical Indicators

Market Signals
Indicator
TYRA
WWW
Relative Strength Index (RSI) 57.49 59.51
Support Level $18.46 $18.98
Resistance Level $22.37 N/A
Average True Range (ATR) 1.04 0.90
MACD 0.27 0.17
Stochastic Oscillator 76.27 58.59

Price Performance

Historical Comparison
TYRA
WWW

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About WWW Wolverine World Wide Inc.

Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; and Work Group. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear. Geographically, the company operates in United States; Europe, Middle East and Africa; Asia Pacific; Canada; and Latin America.

Share on Social Networks: